Faculty of Medicine, Ain Shams University
Cairo, 11591, Egypt
Completed
NCT Number: NCT07365969
Risk of Hysterectomy at Time of Myomectomy
Uterine fibroids are the commonest tumor affecting the female reproductive tract and many instances they are asymptomatic but in some women there does appear to be an association with heavy menstrual blood loss and possibly subfertility. Classically, treatment has been surgical with hysterectomy the most common approach for women who have completed their fertility and myomectomy for those who wish to conceive. The surgery can be carried out laparoscopically, vaginally and abdominally. The aim of this study is to evaluate the risk of hysterectomy at the time of myomectomy, and the associated 30-day postoperative morbidity.
Completed
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
Female
Study type
Observational
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Women planned for abdominal myomectomy in the previous 4 years.
- Availability of complete medical records for pre-, intra- and post-operative data.
Exclusion criteria
- Missing or lacking information in the patients records like preoperative assessment of the fibroid uterus.
- Absence of operative notes and relevant data in the medical files.
Treatment and study plan
Primary outcomes
-
Incidence of hysterectomy at time of myomectomy.
Time frame: Jan 2020- Dec 2024
Secondary outcomes
-
Characteristics of the Myomas who required hysterectomy
Time frame: Jan 2020- Dec 2024
number, site, size, Figo staging
-
Intraoperative complications
Time frame: Jan 2020- Dec 2024
Anesthesia complication, organ injury, blood transfusion.
-
Postoperative complications
Time frame: Jan 2020- Dec 2024
Anemia, hemorrhage, fever, wound infection, wound hematoma
-
Duration of hospital stay
Time frame: Jan 2020- Dec 2024
in days
-
Reoperation
Time frame: Jan 2020- Dec 2024
within 5 days of surgery
-
Readmission after discharge from the hospital
Time frame: Jan 2020- Dec 2024
within 14 days
Sponsors and collaborators
Lead sponsor
Ain Shams University
Other
Registry information
Official study title
The Risk of Hysterectomy at Time of Myomectomy at Ain Shams University Hospital: A Retrospective Cohort Study.
Important dates
- Study start
- 2024
- Primary completion
- 2025
- Study completion
- 2025
- First posted
- Jan 26, 2026
- Registry last updated
- Jan 30, 2026
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Completed
Bilateral Uterine Artery Occlusion During Laparoscopic Myomectomy
NCT07352761
Blood Loss, Surgical, Hemorrhage
Alexandria, El-Shatby, Egypt
View Trial Details
Completed
The Effect of Partial Bladder Filling on Post-operative Time to Void in Minimally Invasive Gynecologic Procedures
NCT02741531
Hysterectomy, Myomectomy
Washington D.C., District of Columbia, United States
View Trial Details
Completed
Ultravision Visual Clearing System in Laparoscopic Hysterectomy and Myomectomy
NCT03634306
Hysterectomy, Myomectomy
St Louis, Missouri, United States
View Trial Details
Completed
Uterine Tourniquet at Open Myomectomy
NCT02049242
Connective Tissue Diseases, Hemorrhage
Erzurum, Yakutiye, Turkey (Türkiye)
View Trial Details